After CAR-T therapy for myeloma: challenge of persistent cytopenias and infections

Authors

Ofrat Beyar‐Katz (ORCID: https://orcid.org/0000-0002-5631-4776)
Anat Stern (ORCID: https://orcid.org/0000-0002-8659-8108)

Institutions

Rambam Health Care Campus (IL)

Publication Details

Journal: Haematologica
Published: 2025-08-21
DOI: https://doi.org/10.3324/haematol.2025.288539
Primary Topic: CAR-T cell therapy research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

After CAR-T therapy for myeloma: challenge of persistent cytopenias and infections

Ofrat Beyar‐Katz, Anat Stern

Aug 21, 2025

5 links

Haematologica

CAR-T cell therapy research

article

After CAR-T therapy for myeloma: challenge of persistent cytopenias and infections

Ofrat Beyar‐Katz, Anat Stern

August 21, 2025article en

Abstract

No abstract available for this paper.

HaematologicaVol. 111(1)

Rambam Health Care Campus (IL)

Openalex Percentile: Top 70%

CAR-T cell therapy research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

After CAR-T therapy for myeloma: challenge of persistent cytopenias and infections — Ofrat Beyar‐Katz, Anat Stern · Haematologica (2025) | TGRS Research Map | TGRS